<DOC>
	<DOCNO>NCT01048918</DOCNO>
	<brief_summary>The purpose study identify tumor cell bloodstream ( Circulating Tumor Cells , CTC 's ) patient 's locally advanced metastatic ( stage IV ) breast cancer . Analyzing tumor helpful guide therapy ; however , research suggest number tumor cell find bloodstream ( CTC 's ) signifies aggressive behavior increase difficulty eliminate cancer . This research help develop good way treat breast cancer could tailor patient may adjust patient 's individual need .</brief_summary>
	<brief_title>Characterization Circulating Tumor Cells ( CTC-s ) Patients With Locally Advanced Metastatic Stage IV Breast Cancer</brief_title>
	<detailed_description>Up 60 mL blood collect patient 6 time point . Samples deliver Bruce Laboratory ( Palo Alto Research Center ) immunolabeling FAST scanning . The FAST scanning utilize CK+ , CD45-and DAPI+ label well cell morphology confirm collaborate pathologist select CTC technology allow assessment four additional protein expression surface CTC 's . Additional sample propose time point place ice send Wang Laboratory purpose extract RNA/microRNA proteins CTC 's profiling analysis . Benefits society , individual . Knowledge obtain apply two technology may help good selection therapy , early detection progression , possibly well diagnosis development target therapeutic agent future .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<criteria>Patients must &gt; 18 year old . Patients treat breast cancer City Hope ( COH ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Circulating tumor cell breast cancer</keyword>
</DOC>